🐦 推特Wall St EngineCodex · 实盘不做把握 5/10
北京时间·🕒 发布 07-30 19:15:12时区推断·⟳ 抓取 07-30 19:15:35·⚡ 决策 08-01 02:36:16 +1d07h·87.8 天前
奥驰亚二季度EPS小幅不及预期但上调全年指引下限
二季度调整后EPS为1.48美元，低于1.50美元预期，但收入基本贴近预期且全年EPS指引下限从5.56美元上调至5.61美元。
📄 原文Wall St Engine@wallstengine↗ 原文
ALTRIA $MO Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $5.36B (Est. $5.35B) 🟡; +1.2% YoY 🔹 Adj. EPS: $1.48 (Est. $1.50) 🔴; +2.…
不做 奥驰亚（MO.US）
财报是混合信号：EPS小幅miss和口含烟草下滑偏负，但全年EPS指引下限上调、资本回报仍在，且消息已被美股至少一个完整交易日消化；当前不追多，也未达到强空催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 奥驰亚提前公告将于2026-07-30美东约07:00发布二季度和上半年业绩，财报日历本身已可预期。
- 公司计划在盘前发布业绩，信号内容对应二季度EPS小幅miss、指引下限上调和CapEx上调。
- 媒体报道利润下降、调整后EPS低于预期、口含烟草业务走弱，并提到盘前股价下跌。市场反应:WSJ报道盘前跌至约72.40美元，约跌3.4%。
- 同日市场报道显示奥驰亚在财报后显著下跌，说明第一轮重定价已经发生。市场反应:MarketWatch同业报道中称奥驰亚7月30日下跌9.32%。
关键理由
- 二季度调整后EPS为1.48美元，低于1.50美元预期，但收入基本贴近预期且全年EPS指引下限从5.56美元上调至5.61美元。
- 口含烟草业务净收入同比下降5.3%，但烟草可燃品业务净收入同比仍增长0.7%，事件是分部结构压力而非全面盈利坍塌。
- 财报已在美股盘前发布并经过至少一个完整交易日消化，当前盘中再追多或追空都缺少新增edge。
主要风险
- 若口含烟草业务下滑持续扩大，市场可能继续下修奥驰亚无烟产品转型预期。
- 行情工具返回超时，未能用stock_quote确认当前实时价，最终不把无法取价作为不做理由。
反向证据
- 做空前查反向 · 来源 web · 日期 2026-07-30 · 影响 weakens
反向利好包括全年EPS指引下限上调和持续资本回报，削弱把小幅EPS miss升级为强空催化的依据。
检索:Altria Q2 2026 earnings EPS miss guidance raised lower end oral tobacco decline 原文 ↗ - 做多前查反向 · 来源 web · 日期 2026-07-31 · 影响 weakens
财报后已有明显负向市场反应，且口含烟草业务下滑和EPS miss不支持基于指引下限上调追多。
检索:Altria Q2 2026 stock reaction July 30 2026 EPS miss 原文 ↗
工具调用 · 历史记录,结果未知(2 种)
- stock_quote · 结果未知
- kb_search · 结果未知
原文全文
展开原文 · 825 字
ALTRIA $MO Q2’26 EARNINGS HIGHLIGHTS
🔹 Revenue: $5.36B (Est. $5.35B) 🟡; +1.2% YoY
🔹 Adj. EPS: $1.48 (Est. $1.50) 🔴; +2.8% YoY
Raises FY26 Guide:
🔹 Adj. EPS: $5.61-$5.72 (Est. $5.69) 🟡
🔹 CapEx: $375M-$450M; raised from $300M-$375M
Segment Net Revenue:
🔹 Smokeable Products: $5.39B; +0.7% YoY
🔹 Oral Tobacco: $713M; -5.3% YoY
Capital Return:
🔹 Dividend: $1.8B
🔹 Buybacks: $55M
🔹 Remaining Authorization: $665M
Comments:
🔸 “We delivered strong first-half results, driving adjusted diluted EPS growth of 4.9%, and returned nearly $3.9 billion to shareholders through dividends and share repurchases combined.”
🔸 “We are raising the lower-end of our full-year 2026 guidance. We now expect to deliver adjusted diluted EPS in a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from a base of $5.42 in 2025.”
🔹 Revenue: $5.36B (Est. $5.35B) 🟡; +1.2% YoY
🔹 Adj. EPS: $1.48 (Est. $1.50) 🔴; +2.8% YoY
Raises FY26 Guide:
🔹 Adj. EPS: $5.61-$5.72 (Est. $5.69) 🟡
🔹 CapEx: $375M-$450M; raised from $300M-$375M
Segment Net Revenue:
🔹 Smokeable Products: $5.39B; +0.7% YoY
🔹 Oral Tobacco: $713M; -5.3% YoY
Capital Return:
🔹 Dividend: $1.8B
🔹 Buybacks: $55M
🔹 Remaining Authorization: $665M
Comments:
🔸 “We delivered strong first-half results, driving adjusted diluted EPS growth of 4.9%, and returned nearly $3.9 billion to shareholders through dividends and share repurchases combined.”
🔸 “We are raising the lower-end of our full-year 2026 guidance. We now expect to deliver adjusted diluted EPS in a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from a base of $5.42 in 2025.”
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。